South Carolina Retina Institute (SCRI) may, for certain patient eye conditions, administer XIPERE® – a revolutionary therapeutic eye treatment that received FDA approval in October 2021.
We focus on helping our patients retain their vision.
South Carolina Retina Institute (SCRI) may, for certain patient eye conditions, administer XIPERE® – a revolutionary therapeutic eye treatment that received FDA approval in October 2021.